Family Members At INcreased-risk for Developing Inflammatory Bowel Disease
NCT06655415 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2024-12-20
Summary
First-degree relatives of people with inflammatory bowel disease ("IBD," including Crohn's disease and ulcerative colitis) have an increased risk for developing IBD themselves. This study will follow unaffected first-degree relatives (who do not have IBD) over time to understand if their behaviors, diet, and biomarkers for IBD can help predict who gets IBD and if IBD can be prevented in these high-risk individuals. Participants will be asked once per year to complete a questionnaire and have their blood, stool, and urine collected. The anticipated length of the study (registry) is approximately 10 years or longer. Parts of this study, such as the questionnaires and stool and urine collection, may be done from home, while other parts, such as the blood draw, will need to be done from Massachusetts General Hospital.
Conditions
- Inflammatory Bowel Disease (IBD)
- Ulcerative Colitis (UC)
- IBD-unclassified (IBD-U)
- Indeterminate Colitis
- Crohn's Disease Colon
- Crohn's Colitis
- Crohn's Ileocolitis
- Crohn's Gastritis
- Crohn's Jejunitis
- Crohn's Duodenitis
- Crohn's Esophagitis
- Ulcerative Proctitis
- Ulcerative Proctosigmoiditis
Sponsors & Collaborators
-
Massachusetts General Hospital
lead OTHER
Principal Investigators
-
Emily W Lopes, MD, MPH · Massachusetts General Hospital
Eligibility
- Min Age
- 14 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-12-18
- Primary Completion
- 2034-12-31
- Completion
- 2034-12-31
Countries
- United States
Study Locations
More Related Trials
-
Personalized Risk Estimation for Crohn's Disease (PRE-Crohn's): Implementation and Feasibility
NCT05332639 ·Status: RECRUITING ·Phase: NA
-
Genomic/Epigenomic Biomarkers of Deregulation of Immune System in Inflammatory Bowel Diseases
NCT02878395 ·Status: UNKNOWN
-
Prevalence, Characteristics, Management, and Outcomes of Difficult-to-treat Inflammatory Bowel Disease
NCT06551194 ·Status: RECRUITING
-
Predictors of Prognosis in IBD Patients
NCT05653011 ·Status: RECRUITING
-
Immune Regulation in Ulcerative Colitis or Crohn s Disease
NCT00001184 ·Status: RECRUITING
-
Early Postoperative Recurrence in Crohn's Disease: Predictors of Research Targeting the Constitutional Mutation of IRGM
NCT01663142 ·Status: COMPLETED
-
Improving the Quality of Care for Adults With Inflammatory Bowel Disease
NCT02791854 ·Status: ENROLLING_BY_INVITATION
-
Precision Crohn's Disease Management Utilizing Predictive Protein Panels (ENvISION)
NCT04131504 ·Status: COMPLETED
-
Study of Inflammatory Markers (VNN1) in Crohn Disease and Ulcerative Colitis.
NCT02304666 ·Status: UNKNOWN ·Phase: NA
-
IDENTIFICATION OF PROGNOSTIC AND PREDICTIVE BIOMARKERS IN INFLAMMATORY BOWEL DISEASE
NCT03809728 ·Status: RECRUITING ·Phase: NA
-
Prevalence of Lymphoma in IBD
NCT00577538 ·Status: COMPLETED
-
Combined PET-MRI in the Diagnostics of Chronic Inflammatory Bowel Diseases (IBD)- a Feasibility Study
NCT02364973 ·Status: COMPLETED
-
Inflammatory Bowel Disease Tracker (IBD Tracker)
NCT03953794 ·Status: WITHDRAWN
-
Microbiome and Genetic Analysis of Familial IBD
NCT03515070 ·Status: COMPLETED
-
Study of the Psychometric Properties of Two Questionnaires for Measuring Disease Flare-up in IBD
NCT06214299 ·Status: NOT_YET_RECRUITING
-
Research and Follow-up of the Determinants of the Progression and Complications of Inflammatory Bowel Diseases Treated or Not With Immunosuppressants.
NCT07172945 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Genetic, Serological Fecal and Clinical Markers in Siblings of Children With Inflammatory Bowel Disease
NCT02181153 ·Status: COMPLETED ·Phase: NA
-
Predictors of Non-response and Loss of Response in IBD Patients Treated With Anti-TNF
NCT01605188 ·Status: COMPLETED
-
A Study to Evaluate Biomarkers in Moderate to Severe Ulcerative Colitis (UC) Patients Treated With Different Targeted Therapies
NCT05456893 ·Status: RECRUITING
-
The Role of Gut Microbiome in Predicting Comorbidities and Complications in Children With Inflammatory Bowel Disease
NCT05652491 ·Status: WITHDRAWN
-
Self-care in Patients Affected by Inflammatory Bowel Disease and Caregivers' Contribution to Self-care
NCT06015789 ·Status: COMPLETED
-
Evaluation of Molecular Mechanisms of Non-response to Therapy in Patients With Inflammatory Bowel Disease
NCT05733845 ·Status: RECRUITING ·Phase: NA
-
Serologic Markers for Inflammatory Bowel Disease During Clinical Forms With Weak or Strong Evolution Capacities
NCT01216514 ·Status: COMPLETED
-
Predictors of Mucosal Healing in Inflammatory Bowel Disease (IBD) Patients Treated With Anti-TNF
NCT01605175 ·Status: COMPLETED
-
Evaluate Established Anti-DEFA5 mAbs Diagnostic Efficacy and Safety in IBD
NCT05663671 ·Status: UNKNOWN